Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- ChecktodayChange DetectedRemoved the related topics 'Schizophrenia' and 'MedlinePlus Genetics' from the page. This reduces contextual tagging and external links but does not alter the study's core information or eligibility details.SummaryDifference0.1%

- Check7 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedMinor updates to related topics and site revision labeling were added, with no changes to core study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedRelated topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed from the page. The core study content and eligibility information remain unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded topic tags for Schizophrenia and a MedlinePlus Genetics related topics section, which enhances context and discoverability for the study.SummaryDifference0.1%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.